A. Philippot

发表

Are Incentive Contract Settlements Nonevents?*

Marie‐Hélène Gagnon, A. Philippot, 2018, International Review of Finance.

Safety and immunogenicity of a SARS-CoV-2 recombinant protein nanoparticle vaccine (GBP510) adjuvanted with AS03: a phase 1/2, randomized, placebo-controlled, observer-blinded trial

Y. K. Kim, A. Walls, D. Veesler, 2022, medRxiv.

Analysts’ reinitiations of coverage and market underreaction

A. Philippot, 2018, Journal of Banking & Finance.

Essays in Empirical Finance

A. Philippot, 2015 .